Complementary therapies and the NHS
This week the BMJ reports that the U.S. is not the only country involved in the quagmire of evaluating complementary medical therapies (CAM). Citizens in both the US and the UK are voting for CAM with their feet, based on anecdotes and uncertain evidence. The BMJ author notes that the popularity of CAM should not be confused with its value. Payment by reimbursement agents should be based on effectiveness, not politics or popularity.